Exhibit 1.01
ZIMVIE INC.
Conflict
Minerals Report
For the Reporting Period from January 1, 2023 to December 31, 2023
This Conflict Minerals Report (this Report) of ZimVie Inc. (ZimVie, the Company, we, our or
us) has been prepared pursuant to Rule 13p-1 and Form SD (collectively, the Rule) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from
January 1, 2023 to December 31, 2023.
The Rule imposes certain reporting obligations on Securities and Exchange Commission (SEC)
registrants whose products contain cassiterite, columbite-tantalite (coltan), gold, wolframite, or their derivatives, which are limited to tantalum, tin, and tungsten (collectively, conflict minerals) that are necessary to the
functionality or production of their products (such minerals are referred to as necessary conflict minerals). For products which contain necessary conflict minerals, the registrant must conduct in good faith a reasonable country of
origin inquiry designed to determine whether any of the conflict minerals originated in the Democratic Republic of the Congo (DRC) or an adjoining country. If, based on such inquiry, the registrant knows or has reason to believe that any
of the necessary conflict minerals contained in its products originated or may have originated in the DRC or an adjoining country and knows or has reason to believe that those necessary conflict minerals may not be solely from recycled or scrap
sources, the registrant must conduct due diligence on the source and chain of custody of the necessary conflict minerals contained in those products.
Pursuant to SEC guidance issued April 29, 2014 and the SEC order issued May 2, 2014, we are not required to describe any of our products as
DRC conflict free or having not been found to be DRC conflict free, and, therefore, we make no conclusion in this regard in this Report. Furthermore, given that we have not voluntarily elected to describe any of
our products as DRC conflict free, an independent private sector audit of this Report has not been conducted.
Company and Products
Overview
We are a leading medical technology company. During 2023, we developed, manufactured, and marketed a comprehensive portfolio of products and
solutions designed to support dental tooth replacement and restoration procedures and treat a wide range of spine pathologies. Our primary customers in 2023 included oral surgeons, dental specialists, general dentists, dental laboratories, dental
service organizations, spine surgeons, hospitals, ambulatory surgery center administrators, and third-party distributors, making ZimVie the final step in the supply chain prior to these products reaching the end customer.
Reasonable Country of Origin Inquiry
Our reasonable
country of origin inquiry is discussed in the Specialized Disclosure Report on Form SD to which this Report is attached as an exhibit.
Due Diligence
Framework
We designed our due diligence measures to be in conformity, in all material respects, with the internationally recognized due diligence
framework as set forth in the Organisation for Economic Co-operation and Development Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas and related
supplements for gold and for tin, tantalum and tungsten.
Due Diligence Measures Undertaken
We are a downstream consumer of necessary conflict minerals. In most cases, there are several third parties in the supply chain between the original source of
these minerals and us. We do not purchase necessary conflict minerals directly from mines, smelters, or refiners; therefore, we rely on our suppliers to provide information regarding the origin of these minerals. We believe smelters and refiners are
best situated to identify the sources of conflict minerals, and, therefore, we have taken steps to identify the smelters and refiners of necessary conflict minerals in our supply chain.